Company / Current Assets
Cardiff Oncology, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$60.1M
FY2025
5-year range
$60.1M / $146.1M
FY2021-FY2025
Trend
-36.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 10 years, ranging from $9M in FY2017 to $146M in FY2021.
Based on SEC 10-K filings.
$60M in FY2025 with a 5-year CAGR of -14.7%.
Declined from $77M to $60M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -18.6%
- 5-Year CAGR
- -14.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -14.7%, indicating a declining trend.
- In FY2025, current assets decreased 36.7% year-over-year.
- Peak current assets was recorded in FY2021.
- Lowest current assets in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $60.1M | -36.7% |
| FY2024 | $95.1M | +22.8% |
| FY2023 | $77.4M | -30.4% |
| FY2022 | $111.3M | -23.8% |
| FY2021 | $146.1M | +9.6% |
| FY2020 | $133.4M | +1074.6% |
| FY2019 | $11.4M | -11.1% |
| FY2018 | $12.8M | +34.8% |
| FY2017 | $9.5M | -75.7% |
| FY2016 | $39.0M | -43.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026